TrialFrontiers in immunology2025

A phase II randomized trial of individualized neoantigen peptide vaccine combined with unusual radiotherapy (iNATURE) in advanced solid tumors-GCOG0028.

Yan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.